Freshfields has advised EQT Private Equity on its entry into exclusive negotiations to partner with Cerba HealthCare
Freshfields Bruckhaus Deringer (‘Freshfields’) has advised EQT Private Equity on its entry into exclusive negotiations to partner with Cerba HealthCare, a leading player in medical diagnosis.
Cerba HealthCare, headquartered in France and firmly established in Europe and Africa through its historical routine and specialty biology expertise, also operates globally through its clinical trials business unit for the validation of new compounds and vaccines. It stands as a unique group in the diagnosis market, covering the needs for diagnostic tools and expertise for patients, physicians, hospitals and the pharmaceutical industry.
The transaction is subject to administrative notifications and regulatory approvals.
The Freshfields team includes Florent Mazeron, partner, Victor Quilleré, senior associate, Manon Serrus and Anne-Priscille Coulot, associates, for corporate aspects; Pascal Cuche, partner, Tanguy Bardet, senior associate, and Louise Bragard, associate, for regulatory aspects; Gwen Senlanne, partner, Marie-Camille Chenique, senior associate, and Jérôme Verneret, associate, for employment aspects; Aude Guyon, counsel, Hélène Lallemand, senior associate, and Laéna Bouafy, associate, for data protection aspects; and Emmanuelle Brunelle, senior associate, and Alice Sich, associate, for compliance aspects.